Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Penka

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Vnitrni Lekarstvi|October 26, 2012
[Peripartal life-threatening hemorrhage - interdisciplinary consensus opinion]J Kvasnička, M Balík, T Binder, et al.
Vnitrni Lekarstvi|December 19, 2009
[The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin]M Penka, J Schwarz, T Pavlík, et al.
Vnitrni Lekarstvi|June 15, 2006
[Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR]M Penka, M Doubek, J Schwarz, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 13, 2011
Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myelomaP Kessler, L Pour, E Gregora, et al.
Vnitrni Lekarstvi|August 19, 2007
[Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006]M Penka, J Schwarz, T Pavlík, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Vnitrni Lekarstvi|October 26, 2012
[Peripartal life-threatening hemorrhage - interdisciplinary consensus opinion]J Kvasnička, M Balík, T Binder, et al.
Vnitrni Lekarstvi|December 19, 2009
[The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin]M Penka, J Schwarz, T Pavlík, et al.
Vnitrni Lekarstvi|June 15, 2006
[Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR]M Penka, M Doubek, J Schwarz, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 13, 2011
Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myelomaP Kessler, L Pour, E Gregora, et al.
Vnitrni Lekarstvi|August 19, 2007
[Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006]M Penka, J Schwarz, T Pavlík, et al.
Pageof 11